BAKERSFIELD, Calif. - Petitioners hope to speed up approval of a drug that could benefit a young Bakersfield boy named Anthony.
Five-year-old Anthony has Duchennes muscular dystrophy, his mom, Maria Montero said.
Over 64,000 people have signed a petition to the White House to speed up release of the drug that could help Anthony. About 35,000 more signatures are required for the White House to respond.
Duchenne Muscular Dystrophy affects boys and death usually occurs by age 25. The gene defect causes weak muscles. Walking, motor skills and everyday activities become increasingly difficult.
"We urge the Food and Drug Administration (FDA) to use the Accelerated Approval pathway for approval and access to safe, effective therapies for Duchenne Muscular Dystrophy - the leading genetic killer of children that impacts 1 out of every 3,500 boys born in the United States. It's time for the FDA to Say Yes and make this the first generation of Duchenne survivors."
The deadline for the petition to reach its goal of 100,000 signatures is March 29.